Your browser doesn't support javascript.
loading
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.
Fokkens, W J; Viskens, A-S; Backer, V; Conti, D; De Corso, E; Gevaert, P; Scadding, G K; Wagemann, M; Bernal-Sprekelsen, M; Chaker, A; Heffler, E; Han, J K; Van Staeyen, E; Hopkins, C; Mullol, J; Peters, A; Reitsma, S; Senior, B A; Hellings, P W.
Afiliação
  • Fokkens WJ; Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital - Rozzano (MI), ItalyPersonalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital - Rozzano
  • Viskens AS; Laboratory of Allergy and Clinical Immunology Research Unit, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Backer V; Department of ENT, head and neck surgery and audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Conti D; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.
  • De Corso E; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.
  • Gevaert P; Laboratory of Upper Airways Research, Department of Otorhinolaryngology, University Hospital Ghent, Ghent, Belgium.
  • Scadding GK; Department of Allergy and Rhinology, Royal National ENT Hospital, London, United Kingdom.
  • Wagemann M; Department of Otorhinolaryngology, Universitatsklinikum Disseldorf, Dusseldorf, Germany.
  • Bernal-Sprekelsen M; Department of Otorhinolaryngology, University of Barcelona, Barcelona, Spain; Department of Otorhinolaryngology, hospital clinic Barcelona, Spain.
  • Chaker A; Dept. of Otorhinolaryngology and Center for Allergy and Environment (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany.
  • Heffler E; Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research Hospital - Rozzano (MI), Italy; Department of Biomedical Sciences - Humanitas University - Pieve Emanuele (MI), Italy.
  • Han JK; Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Van Staeyen E; The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium.
  • Hopkins C; Ear, Nose and Throat Department, Guys and St. Thomas Hospital, London, United Kingdom.
  • Mullol J; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic, IDIBAPS, Universitat de Barcelona, CIBERES. Barcelona, Catalonia, Spain.
  • Peters A; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Reitsma S; Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Senior BA; Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hellings PW; Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Laboratory of Allergy and Clinical Immunology Research Unit, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; The European Forum for Research and Ed
Rhinology ; 61(3): 194-202, 2023 Jun 01.
Article em En | MEDLINE | ID: mdl-36999780
ABSTRACT
Severe chronic rhinosinusitis with nasal polyps (CRSwNP) is a debilitating disease with a significant impact on the quality of life (QoL). It is typically characterized by a type 2 inflammatory reaction and by comorbidities such as asthma, allergies and NSAID-Exacerbated Respiratory Disease (N-ERD). Here, the European Forum for Research and Education in Allergy and Airway diseases discusses practical guidelines for patients on biologic treatment. Criteria for the selection of patients who would benefit from biologics were updated. Guidelines are proposed concerning the monitoring of the drug effects that provide recognition of responders to the therapy and, subsequently, the decision about continuation, switching or discontinuation of a biologic. Furthermore, gaps in the current knowledge and unmet needs were discussed.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinusite / Produtos Biológicos / Rinite / Pólipos Nasais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinusite / Produtos Biológicos / Rinite / Pólipos Nasais Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article